BMRN vs SMC · P/E 40, rev $1.76B vs P/E 5.6, rev $562.1M
Biomarin Pharmaceutical Inc (BMRN) versus Summit Midstream Corporation (SMC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Summit Midstream Corporation (SMC) is a oil & gas midstream company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SMC revenue for 2025-12-31 was $562.1M. Net income was -$5.9M. Revenue was up 30.8% from 2024-12-31 to 2025-12-31. SMC currently screens at market cap $368.3M and trailing P/E 5.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SMC currently screens at market cap $368.3M and trailing P/E 5.6.
Not investment advice. Open the BMRN and SMC stock pages for the full models.
Not investment advice.